Literature DB >> 12139307

Metabolomics and biochemical profiling in drug discovery and development.

Steven M Watkins1, J Bruce German.   

Abstract

Metabolomics brings a different and complementary perspective to biomedical research and therapeutic development. Metabolites are measurable, directly responsible for health, and changeable through intervention. By definition, the concentrations of metabolites are the direct reflection of metabolism, and by measuring changes in metabolite concentrations, the full range of biochemical effects induced by a therapeutic intervention can be determined. In a clinical setting, metabolomics can be used to diagnose or predict disease, stratify patient populations by their specific metabolism, or to determine the safety or efficacy of a therapeutic intervention. Metabolomics is useful in virtually all aspects of biomedical research, and it is likely to evolve into an essential component of the drug discovery and development process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139307

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  16 in total

1.  Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry peak sorting algorithm.

Authors:  Cheolhwan Oh; Xiaodong Huang; Fred E Regnier; Charles Buck; Xiang Zhang
Journal:  J Chromatogr A       Date:  2007-12-03       Impact factor: 4.759

Review 2.  Target profiling of small molecules by chemical proteomics.

Authors:  Uwe Rix; Giulio Superti-Furga
Journal:  Nat Chem Biol       Date:  2009-09       Impact factor: 15.040

3.  Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining.

Authors:  Tiejun Cheng; Qingliang Li; Yanli Wang; Stephen H Bryant
Journal:  J Chem Inf Model       Date:  2011-08-18       Impact factor: 4.956

4.  Genomic analysis of mouse retinal development.

Authors:  Seth Blackshaw; Sanjiv Harpavat; Jeff Trimarchi; Li Cai; Haiyan Huang; Winston P Kuo; Griffin Weber; Kyungjoon Lee; Rebecca E Fraioli; Seo-Hee Cho; Rachel Yung; Elizabeth Asch; Lucila Ohno-Machado; Wing H Wong; Constance L Cepko
Journal:  PLoS Biol       Date:  2004-06-29       Impact factor: 8.029

5.  Separation technique for the determination of highly polar metabolites in biological samples.

Authors:  Yusuke Iwasaki; Takahiro Sawada; Kentaro Hatayama; Akihito Ohyagi; Yuri Tsukuda; Kyohei Namekawa; Rie Ito; Koichi Saito; Hiroyuki Nakazawa
Journal:  Metabolites       Date:  2012-08-16

6.  A mapping of drug space from the viewpoint of small molecule metabolism.

Authors:  James Corey Adams; Michael J Keiser; Li Basuino; Henry F Chambers; Deok-Sun Lee; Olaf G Wiest; Patricia C Babbitt
Journal:  PLoS Comput Biol       Date:  2009-08-21       Impact factor: 4.475

7.  Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation.

Authors:  C Webhofer; P Gormanns; V Tolstikov; W Zieglgänsberger; I Sillaber; F Holsboer; C W Turck
Journal:  Transl Psychiatry       Date:  2011-12-13       Impact factor: 6.222

8.  Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome.

Authors:  Yevgeniya I Shurubor; Wayne R Matson; Walter C Willett; Susan E Hankinson; Bruce S Kristal
Journal:  BMC Clin Pathol       Date:  2007-11-12

9.  Meclizine inhibits mitochondrial respiration through direct targeting of cytosolic phosphoethanolamine metabolism.

Authors:  Vishal M Gohil; Lin Zhu; Charli D Baker; Valentin Cracan; Abbas Yaseen; Mohit Jain; Clary B Clish; Paul S Brookes; Marica Bakovic; Vamsi K Mootha
Journal:  J Biol Chem       Date:  2013-10-19       Impact factor: 5.157

10.  Metabonomics study of the therapeutic mechanism of Gynostemma pentaphyllum and atorvastatin for hyperlipidemia in rats.

Authors:  Miao Wang; Fei Wang; Yinan Wang; Xiaonan Ma; Min Zhao; Chunjie Zhao
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.